Clinical Trials Using Nimotuzumab
Clinical trials are research studies that involve people. The clinical trials on this list are studying Nimotuzumab. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Nimotuzumab and Nivolumab in Treating Patients with Advanced Non-small Cell Lung Cancer or Squamous Cell Head and Neck Cancer
This phase I / II trial studies the best dose and side effects of nimotuzumab when giving together with nivolumab and to see how well they work in treating patients with non-small cell lung cancer or squamous cell head and neck cancer that has spread to other places in the body and usually cannot be cured or controlled with treatment. Monoclonal antibodies, such as nimotuzumab, may interfere with the ability of tumor cells to grow and spread. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body’s immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving nimotuzumab and nivolumab may work better in treating patients with non-small cell lung cancer.
Location: Roswell Park Cancer Institute, Buffalo, New York